Organisation and financing of chronic dialysis in Belgium

Cleemput I, Beguin C, de la Kethulle Y, Gerkens S, Jadoul M, Verpooten G, De Laet C
Record ID 32006001281
English
Authors' recommendations: This HTA focussed on chronic dialysis treatment, its organisation, financing and patientrelated issues in Belgium. End-stage renal disease is a life-threatening condition that has a significant impact on patients’ and their families’ life. Renal transplantation is the treatment of choice for ESRD. Patients who cannot be transplanted or have to wait for a kidney transplant are treated by means of one of the different dialysis modalities: hospital HD, satellite HD, home HD, CAPD or APD. Dialysis is an expensive treatment, both for society and for patients. With the population growing older the dialysis population increases. This increases the financial burden of ESRD. As for all health care interventions, it is important to reflect about measures to ensure that dialysis patients receive appropriate care at an acceptable cost. We hope this HTA provides useful information for the development of such a policy for ESRD treatment.
Details
Project Status: Completed
URL for project: http://kce.fgov.be/index_en.aspx?SGREF=9470&CREF=14964
Year Published: 2010
URL for published report: http://kce.fgov.be/index_en.aspx?SGREF=9470&CREF=14964
English language abstract: An English language summary is available
Publication Type: Not Assigned
Country: Belgium
MeSH Terms
  • Accreditation
  • Belgium
  • Costs and Cost Analysis
  • Patient Satisfaction
  • Reimbursement, Incentive
  • Renal Dialysis
  • Renal Replacement Therapy
Contact
Organisation Name: Belgian Health Care Knowledge Centre
Contact Address: Administrative Centre Botanique, Doorbuilding (10th floor), Boulevard du Jardin Botanique 55, B-1000 Brussels, Belgium tel: +32 2 287 33 88 fax: +32 2 287 33 85
Contact Name: info@kce.fgov.be
Contact Email: info@kce.fgov.be
Copyright: Belgian Health Care Knowledge Centre (KCE)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.